KRYS
Krystal Biotech, Inc.Company with tickers: KRYS
CIK
1711279
CUSIP
501147102
Shares Outstanding
29,479,756
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $116,357,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $62,668,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| Research & Development | $15,331,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| Operating Income | $53,689,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| Net Income | $55,932,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| EPS (Basic) | $1.91 | USD/shares | 2026-03-31 | 10-Q | 2026-05-04 |
| EPS (Diluted) | $1.83 | USD/shares | 2026-03-31 | 10-Q | 2026-05-04 |